Clinical Trial Update: COVID-19 Antibody Responses In Cystic Fibrosis

View source ↗

Summary

A clinical trial is recruiting to study COVID-19 antibody responses in individuals with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Pilar Azevedo | Conditions: COVID-19, Cystic Fibrosis | Status: RECRUITING